首页> 外文OA文献 >53P Aromatase inhibitor and cyclin-dependent kinase 4/6 inhibitor treated HR+/HER2- metastatic breast cancer differ to those treated with Aromatase inhibitors alone on progression

【2h】

53P Aromatase inhibitor and cyclin-dependent kinase 4/6 inhibitor treated HR+/HER2- metastatic breast cancer differ to those treated with Aromatase inhibitors alone on progression

机译：53P芳香酶抑制剂和细胞周期蛋白依赖性激酶4/6抑制剂处理的HR + / HER2-转移性乳腺癌不同于用芳香酶抑制剂的进展处理的那些

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
I. Weerasena; L. Spalding; H. Martin; A. Redfern;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors. [J] . Motomura K, Ishitobi M, Komoike Y, Oncology: International Journal of Cancer Research and Treatment . 2010,第1a2期

机译：雌激素受体β的表达和雌激素受体α丝氨酸167的磷酸化与芳香化酶抑制剂治疗的转移性乳腺癌患者的无进展生存相关。
2. Outcomes of Older Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer Treated With a CDK4/6 Inhibitor and an Aromatase Inhibitor: An FDA Pooled Analysis [J] . Howie Lynn J., Singh Harpreet, Bloomquist Erik, Journal of Clinical Oncology . 2019,第36期

机译：用CDK4 / 6抑制剂和芳香糖酶抑制剂治疗患有激素受体阳性的老年妇女的成果，人表皮生长因子受体阴性转移乳腺癌：FDA汇总分析
3. N0539 phase ii trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: A north central cancer treatment group (now alliance) trial [J] . TanW.W., DueckA.C., FlynnP., Annals of oncology: official journal of the European Society for Medical Oncology . 2013,第10期

机译：N0539氟维司群和贝伐单抗在先前用芳香酶抑制剂治疗的转移性乳腺癌患者中的II期临床试验：北中部癌症治疗组（现为联盟）试验
4. MORPHOLOGICAL ANALYSIS OF COLON CANCER CELL TREATED WITH AEE788, A DUAL TYROSINE KINASE INHIBITOR AND/OR CELEXOXIB, A COX-2 SPECIFIC INHIBITOR- IMAGE PROCESSING APPROACH [C] . P Venkatesan, M Muthu Rama Krishnan, Soumen Das, International Conference on Electronic Design and Signal processing . 2012

机译：用AEE788处理的结肠癌细胞的形态学分析，双酪氨酸激酶抑制剂和/或Celexoxib，COX-2特异性抑制剂 - 图像处理方法
5. The Genetics of Aromatase Inhibitor-related Phenotypes in Postmenopausal Women with ER+ Breast Cancer [D] . Dudenkov, Tanda Tosia Murray. 2017

机译：ER +乳腺癌绝经后妇女芳香酶抑制剂相关表型的遗传
6. First-Line Treatment with a Cyclin-Dependent Kinase 4/6 Inhibitor Plus an Aromatase Inhibitor for Metastatic Breast Cancer in Alberta [O] . Carla P. Amaro, Atul Batra, Sasha Lupichuk 2021

机译：用细胞周期蛋白依赖性激酶4/6抑制剂加上亚伯塔省转移性乳腺癌的芳香酶抑制剂的一线治疗
7. Everolimus plus aromatase inhibitors vs aromatase inhibitors as maintenance therapy after first-line chemotherapy in HR+/HER2- metastatic breast cancer: Final results of the phase III randomized MAIN-A trial [O] . V. Guarneri, S. Cinieri, L. Orlando, 2019

机译：埃莫米斯加芳族酶抑制剂与芳香酶抑制剂在HR + / HER2-转移乳腺癌中的一线化疗后作为维护治疗：III期的最终结果随机的主要试验

53P Aromatase inhibitor and cyclin-dependent kinase 4/6 inhibitor treated HR+/HER2- metastatic breast cancer differ to those treated with Aromatase inhibitors alone on progression

著录项

引文网络

相似文献

相关主题

期刊订阅